Editorial & Columns
#Dr.-Anil-Angrish Archive
Editorial & Columns
Board Characteristics of Pharmaceutical Companies in India
Editorial & Columns
Reporting on Scope 3 Emissions: Learning from Global Pharmaceutical MNCs
Editorial & Columns
Divestitures in Pharmaceutical Industry: Indian Experience
Editorial & Columns
Evaluation and Revival of Special Economic Zones in India
Editorial & Columns
Spin-off by Pharmaceutical Companies in India: Improved Focus and Valuation
Editorial & Columns
Valuation Premium: India-listed Subsidiaries of Pharma and Healthcare MNCs Outshine Parent firms
Editorial & Columns
ESG Frameworks and Pharmaceutical Industry in India
Editorial & Columns
Pharma 2.0: Indian Pharmaceutical Companies strive to Create & Enhance Strength in Biopharmaceuticals
Editorial & Columns
Patent Expiry & Innovator Pharmaceutical Companies : Mechanisms applied to preserve market dominance
- 1
- 2